Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Cancer Treatment and End-of-Life Care

Sinha, Sudha ; Matharu, Jaskirt Kaur ; Jacob, Jean ; Palat, Gayatri ; Brun, Eva LU ; Wiebe, Thomas LU and Segerlantz, Mikael LU (2018) In Journal of Palliative Medicine 21(8). p.1100-1106
Abstract

AIM: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.

PATIENTS AND METHODS: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.

RESULTS: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30... (More)

AIM: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.

PATIENTS AND METHODS: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.

RESULTS: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30 days of life, tumor-specific treatment was given to 39 adult patients and 38 pediatric patients. During the last week in life, 26 adult and 25 pediatric patients, respectively, received tumor-specific treatment. Twenty-six adult and 25 pediatric patients, respectively, were referred to the PCU. End-of-life (EoL) tumor therapy was given to a lesser extent among referred patients.

CONCLUSIONS: Eighty percent of the patients were given tumor-specific treatment near EoL. Half of the patients had been referred for specialized palliative care (SPC).

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Palliative Medicine
volume
21
issue
8
pages
1100 - 1106
publisher
Mary Ann Liebert, Inc.
external identifiers
  • pmid:29768074
  • scopus:85050626973
ISSN
1096-6218
DOI
10.1089/jpm.2017.0695
language
English
LU publication?
yes
id
d84c5991-32c6-4898-8733-093841a17160
date added to LUP
2019-07-01 14:00:31
date last changed
2024-01-16 05:51:04
@article{d84c5991-32c6-4898-8733-093841a17160,
  abstract     = {{<p>AIM: To study to what extent tumor-specific treatment (chemo- or radiotherapy) was given during the last 30 days in life and to examine how many of the patients were referred to a specialized palliative care unit (PCU), at a low-resource governmental hospital in India.</p><p>PATIENTS AND METHODS: Medical records of adult cancer patients deceased between April 1 and May 31 in 2016, and pediatric cancer patients deceased between April 1 and September 30 in 2016 were collected. Data regarding gender, age at admission, cancer diagnosis, tumor-specific treatment received, referral to the PCU, and date of death, were sampled.</p><p>RESULTS: A total of 96 patients (52 adults and 44 pediatric patients) were included in the study. In the last 30 days of life, tumor-specific treatment was given to 39 adult patients and 38 pediatric patients. During the last week in life, 26 adult and 25 pediatric patients, respectively, received tumor-specific treatment. Twenty-six adult and 25 pediatric patients, respectively, were referred to the PCU. End-of-life (EoL) tumor therapy was given to a lesser extent among referred patients.</p><p>CONCLUSIONS: Eighty percent of the patients were given tumor-specific treatment near EoL. Half of the patients had been referred for specialized palliative care (SPC).</p>}},
  author       = {{Sinha, Sudha and Matharu, Jaskirt Kaur and Jacob, Jean and Palat, Gayatri and Brun, Eva and Wiebe, Thomas and Segerlantz, Mikael}},
  issn         = {{1096-6218}},
  language     = {{eng}},
  number       = {{8}},
  pages        = {{1100--1106}},
  publisher    = {{Mary Ann Liebert, Inc.}},
  series       = {{Journal of Palliative Medicine}},
  title        = {{Cancer Treatment and End-of-Life Care}},
  url          = {{http://dx.doi.org/10.1089/jpm.2017.0695}},
  doi          = {{10.1089/jpm.2017.0695}},
  volume       = {{21}},
  year         = {{2018}},
}